Keywords: Tumors, Deuterium
The potential for DMI measurements of deuterated glucose metabolism to differentiate between metabolic subtypes in GBM has been demonstrated in patient-derived xenografts in mice. The glycolytic subtype showed increased lactate labelling whereas two oxidative subtypes showed increased glutamate/glutamine (Glx) labelling. There was decreased lactate labelling in a glycolytic subtype and decreased lactate and Glx labelling in an oxidative subtype within 24 h after the completion of standard-of-care chemoradiotherapy, demonstrating that the technique can also be used to detect early treatment response in this tumor type.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords